Foyston, Gordon, & Payne’s Select Medical SEM Stock Holding History

Foyston, Gordon, & Payne’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-742,877	Closed	-$4.77M	–	73
2015 Q4	$4.77M	Sell	742,877 -627,356	-46%	-$3.92M	0.9%	37
2015 Q3	$7.97M	Buy	1,370,233 +20,412	+2%	+$151K	1.48%	30
2015 Q2	$11.8M	Sell	1,349,821 -205,158	-13%	-$1.72M	1.77%	24
2015 Q1	$12.4M	Sell	1,554,979 -6,440	-0.4%	-$48.1K	1.83%	20
2014 Q4	$12.1M	Sell	1,561,419 -289,908	-16%	-$2.11M	1.73%	26
2014 Q3	$12M	Buy	1,851,327 +182,222	+11%	+$1.41M	1.72%	23
2014 Q2	$14M	Sell	1,669,105 -323,129	-16%	-$2.51M	1.78%	23
2014 Q1	$13.4M	Buy	1,992,234 +264,322	+15%	+$1.6M	1.65%	25
2013 Q4	$10.8M	Buy	1,727,912 +810,677	+88%	+$3.96M	1.34%	29
2013 Q3	$3.99M	Buy	+917,235	New	+$4.19M	0.52%	48

Other funds holding SEM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

NTC

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

EAM

EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return

Foyston, Gordon, & Payne's SEM Position: Q1 2016 in Review

Foyston, Gordon, & Payne sold out of Select Medical (SEM) in Q1 2016, closing a stake of 742,877 shares — an estimated $4.77M sold.

Foyston, Gordon, & Payne first reported a position in SEM in Q3 2013 and held it in 10 quarters. The position peaked at $14M in Q2 2014. 153 funds tracked by Wall St. Rank hold SEM as of Q1 2016.

Foyston, Gordon, & Payne reported no remaining Select Medical position as of Q1 2016 after selling out during the quarter.
Foyston, Gordon, & Payne sold 742,877 Select Medical shares in Q1 2016, an estimated $4.77M.
Foyston, Gordon, & Payne first reported a position in Select Medical in Q3 2013 and held it in 10 quarters.
Foyston, Gordon, & Payne's Select Medical position peaked at $14M in Q2 2014.
153 funds tracked by Wall St. Rank held Select Medical as of Q1 2016.

Based on Foyston, Gordon, & Payne's 13F filing for Q1 2016, filed 13 May 2016.